University of California San Diego

Gordon Bell Special Prize for COVID-19 Research Announced

A team of computational chemists and biologists wins a coveted award in supercomputing for their molecular simulations of SARS-CoV-2

Newswise — This year the Association for Computing Machinery (ACM) issued a special version of the Gordon Bell Prize, one of the most prestigious awards given for outstanding achievements in high performance computing. In recognition of COVID-19 research efforts, the Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research was presented Nov. 19 during the SC20 virtual conference. UC San Diego Computational Chemist and Biophysicist Rommie Amaro’s team, including members of the Amaro Lab, Argonne National Laboratory (ANL) and Oak Ridge National Laboratory, won.

The team led by Amaro and Arvind Ramanathan, computational biologist at ANL, has been exploring the movement of SARS-CoV-2’s spike protein to understand how it behaves and gains access to the human cell. Now, in a first-of-its-kind feat, the team has built a workflow based on artificial intelligence (AI) to more efficiently simulate the spike, and they have scaled the workflow to the Summit supercomputer to gain a deeper understanding of the spike’s mechanisms and accelerate the search for therapeutics or vaccines that might work to mitigate the virus.

“Experimental pictures give us a concept of what these things look like, but they can’t tell us the whole story,” Amaro said. “The only way we can do this is through simulations, and right now we are pushing the capabilities of molecular simulations to the limits of the computer architectures that we have on this earth. This is at the edge of possibilities of what people are capable of doing.”

The team first optimized the Nanoscale Molecular Dynamics (NAMD) and the Visual Molecular Dynamics (VMD) codes, which model the movements of atoms in time and space, on multiple smaller cluster systems: the Frontera supercomputer at the Texas Advanced Computing Center, the Comet system at the San Diego Supercomputer Center, and the ThetaGPU supercomputer at the Argonne Leadership Computing Facility (ALCF). The optimizations prepared them to run their full-scale simulations on the OLCF’s Summit. The OLCF and the ALCF are US Department of Energy (DOE) Office of Science User Facilities located at DOE’s Oak Ridge and Argonne national laboratories, respectively.

After code optimizations, the team was able to successfully scale NAMD to 24,576 of Summit’s NVIDIA V100 GPUs. The results of the team’s initial runs on Summit have led to discoveries of one of the mechanisms that the virus uses to evade detection as well as a characterization of interactions between the spike protein and the protein that the virus takes advantage of in human cells to gain entrance into them—the ACE2 receptor.

“This is one of the first biological systems of the virus that we can learn from to drive scientific discovery,” Amaro said. “Our methods of computing allow us to get down to actually see detailed intricacies of this virus that are useful for understanding not only how it behaves but also its vulnerabilities, from a vaccine development standpoint, and a drug targeting perspective.”

Because one set of the calculations generated a whopping 200 terabytes of data, the team used AI to identify the intrinsic features from the simulations and break down the information to help them interpret what was happening. By layering the experimental data and the simulation data and combining it with their AI-based approach, the researchers were able to capture the virus and its mechanisms in unprecedented detail. The team is also integrating the NAMD code into their workflow pipeline to fully automate the transition from simulation to AI for data processing without gaps.

“We never thought we could use our machine-learning tools at this scale,” Ramanathan said. “Using these AI-based approaches on Summit have helped accelerate the process of truly understanding the motion of these complex systems.”

This research was supported by the Exascale Computing Project; the DOE National Virtual Biotechnology Laboratory, with funding provided by the Coronavirus CARES Act; and the COVID-19 HPC Consortium.

Related Publication: Lorenzo Casalino, Abigail Dommer, Zied Gaieb, Emilia P. Barros, Terra Sztain, Surl-Hee Ahn, Anda Trifan, Alexander Brace, Anthony Bogetti, Heng Ma, Hyungro Lee, Matteo Turilli, Syma Khalid, Lillian Chong, Carlos Simmerling, David J. Hardy, Julio D. C. Maia, James C. Phillips, Thorsten Kurth, Abraham Stern, Lei Huang, John McCalpin, Mahidhar Tatineni, Tom Gibbs, John E. Stone, Shantenu Jha, Arvind Ramanathan, and Rommie E. Amaro. “AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics.” In Proceedings of SC20, Virtual Event, November 16-19, 2020.




Filters close

Showing results

110 of 4147
Newswise: COVID-19 Peer Hub combats vaccine avoidance amid pandemic
Released: 27-Nov-2020 8:05 AM EST
COVID-19 Peer Hub combats vaccine avoidance amid pandemic
University of South Australia

UniSA researchers are evaluating a new vaccination education initiative – the COVID-19 Peer Hub – to help immunisation and public health professionals to tackle the emerging dangers of vaccine hesitancy amid the pandemic.

Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction


Showing results

110 of 4147

close
1.13033